Novartis Tops Pfizer and GSK In South Korea's 2009 Insurance-covered Drug Sales
This article was originally published in PharmAsia News
Executive SummarySEOUL - Novartis Korea edged Pfizer Korea and GlaxoSmithKline Korea last year to be the country's multinational pharma leader in sales for drugs covered by South Korea's national health insurance system
You may also be interested in...
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).